PETMED EXPRESS INC (PETS) stock: key figures, P/E, revenue and dividend

Consumer Staples · United States · ISIN US7163821066

Price
0.94 USD
Market cap
20.90 m USD
P/E (2026)
–
P/S (2026)
0.12
Dividend yield
0.00 %
Net margin
-32.00 %
Return on equity (ROE)
-197.95 %
Return on assets (ROA)
-70.56 %

PETMED EXPRESS INC financials

Fiscal year20252026
Revenue226.97 m USD179.02 m USD
Gross profit69.14 m USD50.22 m USD
Operating income-1.53 m USD-58.67 m USD
EBIT-587,000.00 USD-57.36 m USD
Net income-6.27 m USD-57.29 m USD
Diluted EPS – continuing operations-0.30 USD-2.74 USD

Full history since 2000, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About PETMED EXPRESS INC

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.